Curis
CRIS
$6.59
Share price
-13.29%
Change (1 day)
572.45%
Change (1 year)
Categories
Earnings for Curis (CRIS)
Earnings in 2023 (TTM): -$45.45 M
According to Curis's latest financial reports the company's current earnings (TTM) are -$45.45 M. In 2022 the company made an earning of -$52.45 M a decrease over its 2021 earnings that were of -$40.97 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Curis from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$45.45 M | -13.35% |
| 2022 | -$52.45 M | 28.02% |
| 2021 | -$40.97 M | 65.09% |
| 2020 | -$24.82 M | -8.97% |
| 2019 | -$27.26 M | -4.85% |
| 2018 | -$28.65 M | -41.95% |
| 2017 | -$49.36 M | -14.37% |
| 2016 | -$57.64 M | 83.85% |
| 2015 | -$31.35 M | 109.27% |
| 2014 | -$14.98 M | 69.78% |
| 2013 | -$8.83 M | |
| 2011 | -$7.21 M | 27.76% |
| 2010 | -$5.64 M | -43.87% |
| 2009 | -$10.05 M | -23.44% |
| 2008 | -$13.12 M | 56.66% |
| 2007 | -$8.38 M | -16.71% |
| 2006 | -$10.06 M | 35.81% |
| 2005 | -$7.41 M | 19.02% |
| 2004 | -$6.23 M | -37.24% |
| 2003 | -$9.92 M | -93.34% |
| 2002 | -$0.15 B | 92.82% |
| 2001 | -$77.19 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $24.22 B | -53,402.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.69 B | -19,239.10% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -$61.89 M | 36.18% | 🇺🇸 USA |
 Exelixis EXEL | $0.20 B | -560.55% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$0.13 B | 166.84% | 🇺🇸 USA |
 Cel-Sci
CVM | -$33.09 M | -27.20% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$0.48 B | 953.23% | 🇺🇸 USA |